Sealmatic India Ltd Q1 FY27 Earnings Analysis

- Sealmatic expects a revenue growth of approximately 15% in FY27. - The company plans to add around 300 more API seals in FY27, growing from 900 to about 1,200 seals supplied. - Replacement revenue from previously supplied seals (with about 80% gross margin) is expected to start kicking in from FY27, with significant contribution anticipated in FY28 and beyond. - The company aims to improve profitability, targeting EBITDA margins around 23-24% in FY27, benefiting from reduced below-cost supplies and controlled expenses. - Sealmatic is confident of expanding its market share in industries such as oil & gas (India and Middle East), defense, marine, power, and nuclear sectors over the midterm. - The company is committed to sustainable value creation and expanding its global footprint through existing and new service centers in key regions.

- **Revenue Growth**: Expected to grow by approximately 15% in FY27, reflecting steady progress despite geopolitical challenges. - **EBITDA Margin**: Anticipated improvement in margins for FY27, aiming to recover towards previous levels of 22-24%, up from 17.36% in FY26. - **Profitability**: Profit before tax was 14% of revenue in FY26; future years expected to improve with reduced costs and better operational efficiency. - **Cash Flow**: Operating cash flow expected to turn positive starting FY27, with a more significant improvement seen by FY28. - **API Seal Business**: Additional 300 API seals targeted for FY27, with increasing contributions and improved margin impact in future years. - **Replacement Business**: Expected to contribute higher-margin revenue (around 80% gross margin) starting FY27, enhancing profitability. - **Capital Infusion**: Potential need for additional capital via debt or other means if expansion accelerates further.

- Sealmatic may require additional capital infusion if it increases API seal production significantly or takes on many orders; this capital could be raised via debt or other means. - The company is investing in the expansion of its third manufacturing unit, indicating ongoing capital expenditure to boost production capabilities. - FY27 is expected to have reduced costs in API seals compared to FY26, suggesting a strategic focus on optimizing investments and operational efficiency. - No specific institutional capital infusion or strategic investment deals are confirmed yet, but there is significant interest and attention from institutional investors. - Geographic expansion includes establishing service centers in the Middle East (Oman, Kuwait, etc.) as planned, with no impact from recent Middle East conflicts. - Overall capital infusion decisions will likely depend on growth in API seal demand and order finalizations in coming years.

- Umar Balwa indicated uncertainty about additional capital infusion needs. - If the company increases production of API seals and takes on many orders, there may be a need for capital infusion. - Such infusion could be through creating debt or by other means. - No specific plans or timelines for debt or equity fundraising were mentioned. - The current capital structure may support growth initially, but further expansion might require external capital.

- Current order book as of June 2026 is better compared to June 2025, indicating growth (Page 16). - Approximately 916 critical API seals ordered/executed across UAE, Saudi, Oman, Kuwait, and Iraq. - Of these, 686 seals have been supplied. - Around 230 seals are under execution (Page 11). - For FY27, the company expects to add about 300 more API seals to the order book (Page 14-15). - Internal target for increasing API seals supplied in FY27 is about 300 seals, which is lower than FY26 due to strategic margin and cash flow considerations (Page 14). - Replacement sales business (aftermarket) is expected to start kicking in from FY27 and grow significantly by FY28 (Page 15-16). - The company is actively quoting for nuclear seal packages for new expansions, indicating potential future orders but with long lead times (Page 11).